Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Pilot Study With an Extension Phase to Evaluate the Pharmacokinetics, and to Generate Preliminary Safety, Tolerability, and Efficacy of Perampanel (E2007) Oral Suspension When Given as an Adjunctive Therapy in Pediatric Subjects From 2 to Less Than 12 Years of Age With Epilepsy

NCT01527006 is registered in ClinicalTrials.gov with Eisai Inc. as lead sponsor.

NCT NCT01527006
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01527006 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Pilot Study With an Extension Phase to Evaluate the Pharmacokinetics, and to Generate Preliminary Safety, Tolerability, and Efficacy of Perampanel (E2007) Oral Suspension When Given as an Adjunctive Therapy in Pediatric Subjects From 2 to Less Than 12 Years of Age With Epilepsy
Lead sponsor
Eisai Inc.
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2012
Completion date
April 30, 2015
Enrollment
63 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

central nervous system